Cargando…
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification
BACKGROUND: Adalimumab blocks the action of tumor necrosis factor-α and reduces disease progression in rheumatoid arthritis and psoriatic arthritis. The effects of adalimumab in controlling progression of structural damage in erosive hand osteoarthritis (HOA) were assessed. METHODS: Sixty patients w...
Autores principales: | Verbruggen, Gust, Wittoek, Ruth, Cruyssen, Bert Vander, Elewaut, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371224/ https://www.ncbi.nlm.nih.gov/pubmed/22128078 http://dx.doi.org/10.1136/ard.2011.149849 |
Ejemplares similares
-
Morbid anatomy of ‘erosive osteoarthritis’ of the interphalangeal finger joints: an optimised scoring system to monitor disease progression in affected joints
por: Verbruggen, Gust, et al.
Publicado: (2009) -
Ankylosis of the Finger in Erosive Osteoarthritis
por: Takizawa, Naoho, et al.
Publicado: (2017) -
Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolism
por: Groeneboer, Sara, et al.
Publicado: (2011) -
Hand Erosive Osteoarthritis and Distal Interphalangeal Involvement in Psoriatic Arthritis: The Place of Conservative Therapy
por: Poletto, Elena, et al.
Publicado: (2021) -
Risk factors for the progression of finger interphalangeal joint osteoarthritis: a systematic review
por: Shah, Karishma, et al.
Publicado: (2020)